The information statement highlights the role of artificial intelligence in the remote diagnosis of diabetic retinopathy, emphasizing its potential to improve access to care, timely management, and reduce costs. Effective screening can identify patients needing referrals, with digital retinal imaging aiding early detection. The American Academy of Ophthalmology advocates for the evaluation and regulatory approval of autonomous diagnostic technologies while acknowledging potential medicolegal risks for ophthalmologists.